HRP20160414T1 - Postupak sinteze derivata 3,6-dihidro-1,3,5-triazina - Google Patents

Postupak sinteze derivata 3,6-dihidro-1,3,5-triazina Download PDF

Info

Publication number
HRP20160414T1
HRP20160414T1 HRP20160414TT HRP20160414T HRP20160414T1 HR P20160414 T1 HRP20160414 T1 HR P20160414T1 HR P20160414T T HRP20160414T T HR P20160414TT HR P20160414 T HRP20160414 T HR P20160414T HR P20160414 T1 HRP20160414 T1 HR P20160414T1
Authority
HR
Croatia
Prior art keywords
process according
compound
formula
butanol
solvent
Prior art date
Application number
HRP20160414TT
Other languages
English (en)
Croatian (hr)
Inventor
Stéphanie AUBOURG
Bernard Boudet
Daniel Cravo
Matthias Helmreich
Original Assignee
Poxel Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poxel Sas filed Critical Poxel Sas
Publication of HRP20160414T1 publication Critical patent/HRP20160414T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/10Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HRP20160414TT 2008-05-23 2009-04-24 Postupak sinteze derivata 3,6-dihidro-1,3,5-triazina HRP20160414T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08009483 2008-05-23
EP09749530.3A EP2300444B1 (en) 2008-05-23 2009-04-24 Process for the synthesis of 3,6-dihydro-1,3,5-triazine derivatives
PCT/EP2009/002997 WO2009141040A2 (en) 2008-05-23 2009-04-24 Process for the synthesis of 3,6-dihydro-1,3,5-triazine derivatives

Publications (1)

Publication Number Publication Date
HRP20160414T1 true HRP20160414T1 (hr) 2016-05-20

Family

ID=40791625

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20160414TT HRP20160414T1 (hr) 2008-05-23 2009-04-24 Postupak sinteze derivata 3,6-dihidro-1,3,5-triazina

Country Status (21)

Country Link
US (1) US20110124860A1 (https=)
EP (1) EP2300444B1 (https=)
JP (1) JP5458093B2 (https=)
KR (1) KR101618198B1 (https=)
CN (1) CN102036970A (https=)
AU (1) AU2009250149B2 (https=)
BR (1) BRPI0912512B1 (https=)
CA (1) CA2725011A1 (https=)
CY (1) CY1117855T1 (https=)
DK (1) DK2300444T3 (https=)
EA (1) EA018921B1 (https=)
ES (1) ES2571793T3 (https=)
HR (1) HRP20160414T1 (https=)
HU (1) HUE027532T2 (https=)
IL (1) IL209198A (https=)
MX (1) MX2010012741A (https=)
PL (1) PL2300444T3 (https=)
RS (1) RS54736B1 (https=)
SI (1) SI2300444T1 (https=)
WO (1) WO2009141040A2 (https=)
ZA (1) ZA201009160B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012072663A1 (en) 2010-12-01 2012-06-07 Poxel Separation of triazine derivatives enantiomers using tartaric acid
CN105753801B (zh) * 2016-03-25 2018-06-01 浙江工业大学 一种均三嗪类化合物的制备方法
CA3078163A1 (en) 2017-10-02 2019-04-11 Poxel Methods of treating heart failure with preserved ejection fraction
CA3102412A1 (en) 2018-06-06 2019-12-12 Metavant Sciences Gmbh Methods of treating subjects having diabetes with chronic kidney disease
AU2019286326A1 (en) 2018-06-14 2020-12-10 Poxel Film-coated tablet comprising a triazine derivative for use in the treatment of diabetes
CN114681464B (zh) * 2020-12-28 2024-07-09 南京理工大学 二甲双胍类似物在制备脑缺血再灌注损伤预防和治疗药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2804113B1 (fr) * 2000-01-26 2004-06-18 Lipha Derives animes de dihydro-1,3,5-triazine et leurs applications en therapeutique
CA2510468C (en) * 2002-12-17 2011-01-04 Hamari Chemicals, Ltd. Novel 2,4-diamino-1,3,5-triazine derivative
FR2853650B1 (fr) * 2003-04-10 2006-07-07 Merck Sante Sas Procede de dedoublement d'amines utiles pour le traitement de desordres associes au syndrome d'insulino-resistance
DE102007054416A1 (de) * 2007-11-13 2009-05-14 Studiengesellschaft Kohle Mbh Verfahren zur Herstellung von 3,6-Dihydro-1,3,5- Triazin-Derivaten für die Behandlungen von Erkrankungen, die mit dem Insulinresistenz-Syndrom assoziiert sind

Also Published As

Publication number Publication date
IL209198A0 (en) 2011-01-31
RS54736B1 (sr) 2016-10-31
EA018921B1 (ru) 2013-11-29
JP5458093B2 (ja) 2014-04-02
ES2571793T3 (es) 2016-05-26
DK2300444T3 (en) 2016-05-23
WO2009141040A2 (en) 2009-11-26
EP2300444B1 (en) 2016-04-13
PL2300444T3 (pl) 2016-08-31
BRPI0912512B1 (pt) 2018-09-11
SI2300444T1 (sl) 2016-10-28
IL209198A (en) 2013-11-28
US20110124860A1 (en) 2011-05-26
ZA201009160B (en) 2011-10-26
BRPI0912512A2 (pt) 2015-07-28
CY1117855T1 (el) 2017-05-17
KR20110013498A (ko) 2011-02-09
CA2725011A1 (en) 2009-11-26
WO2009141040A3 (en) 2010-01-21
CN102036970A (zh) 2011-04-27
AU2009250149A1 (en) 2009-11-26
JP2011520930A (ja) 2011-07-21
HUE027532T2 (en) 2016-10-28
MX2010012741A (es) 2010-12-21
AU2009250149B2 (en) 2013-05-23
EA201001828A1 (ru) 2011-04-29
EP2300444A2 (en) 2011-03-30
KR101618198B1 (ko) 2016-05-04

Similar Documents

Publication Publication Date Title
HRP20160414T1 (hr) Postupak sinteze derivata 3,6-dihidro-1,3,5-triazina
HRP20191641T1 (hr) Postupak dobivanja spojeva korisnih kao inhibitora atr kinaze
EA201590023A1 (ru) Новые 4-замещенные производные 1,3-дигидро-2h-бензимидазол-2-она, замещенные бензимидазолами, в качестве противовирусных средств против респираторного синцитиального вируса
NZ597210A (en) Rebaudioside a composition and method for purifying rebaudioside a
MX2014000359A (es) Metodos plaguicidas que utilizan compuestos de 3 - piridin tiazol sustituido y derivados para combatir las plagas de animales ii.
CO5650165A2 (es) Procedimientos para la preparacion de derivados de benzoimidazol
WO2009016460A3 (en) Pyrazole compounds and their use as raf inhibitors
EA201400622A1 (ru) Соединения 2-(замещенный-фенил)циклопентан-1,3-диона и их производные
WO2007147771A3 (en) Tetralin and indane derivatives and uses thereof
EA201070437A2 (ru) Способ получения 2'-дезокси -5-азацитидина (децитабина)
CR11824A (es) Derivados heterocíclicos de la urea y sus métodos de empleo
ES2614997T3 (es) Compuestos reguladores del crecimiento vegetal
RU2013110313A (ru) Аморфные твердые формы гидрохлорида 4-[-2-[[5-метил-1-(2-нафталенил)-1н-пиразол-3-ил]окси]этил]морфолина
RU2013137753A (ru) Твердые формы ингибитора гиразы (r)-1-этил-3-[5-[2-(1-гидрокси-1-метилэтил)пиримидин-5-ил]-7-(тетрагидрофуран-2-ил)-1н-бензимидазол-2-ил]мочевины
JP2013531058A5 (https=)
AR047544A1 (es) Proceso para la preparacion de compuestos de triazol sustituidos
JP2011520930A5 (https=)
NO20071209L (no) Pyrrolderivater, deres fremstilling og deres terapeutiske anvendelse
MX392154B (es) Preparacion de derivados de acido 2-([1,2,3]triazol-2-il)-benzoico.
WO2008093205A3 (en) A method for the purification of rosuvastatin intermediate
WO2007123942A3 (en) Benzodioxane and benzodioxolane derivatives and uses thereof
MXPA05003695A (es) Nuevo proceso para la sintesis de compuestos de 1,3-dihidro-2h-3-benzazepin-2-ona, y aplicacion en la sintesis de ivabradina y sales de adicion de la misma con un acido farmaceuticamente aceptable.
HRP20140942T1 (hr) Postupak pripreme kontrastnih sredstava
NO20080607L (no) Fremgangsmate for fremstilling av losartan og nye mellomprodukter som er anvendelige i en slik fremgangsmate
RU2018122936A (ru) Способ очистки производного бензопирана, его кристаллическая форма и способ получения кристаллической формы